Beardsall, K., Ong, K. K.
, Frystyk, J., Chen, J. W., Ogilvy-Stuart, A. L., Ahluwalia, J., Thomson, M. & Dunger, D. B. (2007).
Early elective insulin therapy prevents hyperglycaemia and increases IGF-1 levels in very low birth weight infants.
J Pediatr,
151(6), 611-617.
Belobrajdic, D. P., Priebe, I. K., Forbes, B.
, Flyvbjerg, A., Chen, J.-W., Cosgrove, L. J.
, Frystyk, J. & Saunders, I. W. (2007).
Assessing the potential usefulness of IGF-related peptides and adiponectin for predicting disease risk.
Growth Hormone and IGF Research,
18(3), 198-204.
https://doi.org/10.1016/j.ghir.2007.08.005Buhl, E. S., Neschen, S., Yonemitsu, S., Rossbacher, J., Zhang, D., Morino, K.
, Flyvbjerg, A., Perret, P., Samuel, V., Kim, J., Cline, G. W.
& Petersen, K. F. (2007).
Increased hypothalamic-pituitary-adrenal axis activity and hepatic insulin resistance in low-birth-weight rats.
American Journal of Physiology: Endocrinology and Metabolism,
293, E1451-8.
Burridge, J. H., Haugland, M.
, Pickering, R. M., Svaneborg, N., Iversen, H. K.
, Christensen, P. B., Haase, J., Brennum, J. & Sinkjaer, T. (2007).
Phase II trial to evaluate the ActiGait implanted drop-foot stimulator in established hemiplegia. Journal of Rehabilitation Medicine,
39(3), 212-8.
https://doi.org/10.2340/16501977-0039Christensen, T., Møller-Larsen, A., Thiel, S., Hansen, T. K., Ellermann-Eriksen, S., Brudek, T. & Petersen, T. (2007).
Innate and adaptive anti-viral immune responses in MS patients treated with interferon-beta. Poster session presented at 23rd Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Prag, Tonga.
Christensen, T., Møller-Larsen, A., Thiel, S., Hansen, T. K., Ellermann-Eriksen, S.
, Brudek, T. & Petersen, T. (2007).
Innate and adaptive anti-viral immune responses in MS patients treated with interferon-beta.
Multiple Sclerosis, S163.
Christiansen, J. J., Andersen, N. H., Sørensen, K. E.
, Pedersen, E. M., Bennett, P., Andersen, M.
, Christiansen, J. S., Jørgensen, J. O. L. & Gravholt, C. H. (2007).
Dehydroepiandrosterone substitution in female adrenal failure: no impact on endothelial function and cardiovascular parameters despite normalization of androgen status.
Clinical Endocrinology,
66(3), 426-433.